RAPT Therapeutics’ stock jumped more than 63% during the pre-market trading session on the US stock market after GSK Plc announced its $2.2 billion equity value acquisition deal. Here’s what investors need to know about the stock and the acquisition update.
Source :- mint – markets Read More
